Company Filing History:

10 out of 1,455

Sanofi

Dropic - Societe Civile De Gestion De Droits De Propriete Industrielle

patents

Years Active: 1986-2002

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6380230 - Carboxamidothiazole derivatives, preparation, pharmaceutical compositions containing them (2002-04-30),

2. 5656648 - Polysubstituted 2-amino-thiazole derivatives (1997-08-12),

3. 5656631 - Pyridazine derivatives (1997-08-12),

4. 5631255 - Pyridazine derivatives (1997-05-20),

5. 5461053 - Pyridazine derivatives (1995-10-24),

6. 5380736 - Heterocyclic substituted 2-acylamino-5-thiazoles, their preparation and (1995-01-10),

7. 5378706 - Fused-thiazole derivatives active on the cholinergic system, and (1995-01-03),

8. 5314889 - Heterocyclic substituted 2-acylamino-5-thiazoles, their preparation and (1994-05-24),

9. 5250725 - Aromatic acid intermediates (1993-10-05),

10. 5232921 - Thiazole derivatives active on the cholinergic system, process for (1993-08-03),

11. 5086053 - Derivatives of 1,3,4-thiadiazole, a method of obtaining them and (1992-02-04),

12. 5079241 - Cephalosporin derivatives and pharmaceutical compositions in which they (1992-01-07),

13. 4950661 - Cephalosporin derivatives, and their application as antibiotics (1990-08-21),

14. 4761430 - Arylbenzenesulfonamide containing pharmaceutical compositions (1988-08-02),

15. 4656166 - Antibiotic compounds derived from cephalosporins, process for their (1987-04-07),

Title: The Innovative Contributions of Dominique Olliero

Introduction

Dominique Olliero is a prominent inventor based in Montpellier, France. He has made significant contributions to the field of pharmaceuticals, holding a total of 16 patents. His work focuses on the development of novel compounds that have potential therapeutic applications.

Latest Patents

Among his latest patents are the Carboxamidothiazole derivatives, which include preparations and pharmaceutical compositions containing them. Additionally, he has developed pyridazine derivatives that serve as ligands for cholinergic receptors, particularly the M1 type. These innovations highlight his commitment to advancing medical science through his research.

Career Highlights

Throughout his career, Dominique Olliero has worked with notable companies such as Sanofi and Elf Sanofi. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Dominique has collaborated with esteemed colleagues, including Roger Brodin and Robert Boigegrain. These partnerships have fostered an environment of innovation and creativity, leading to the development of impactful inventions.

Conclusion

Dominique Olliero's work exemplifies the spirit of innovation in the pharmaceutical field. His numerous patents and collaborations reflect his dedication to improving healthcare through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

1 patent pending (CIPO):

Please report any incorrect information to support@idiyas.com